Top

Timothy E Newhook, MD, FSSO, FACS

Department of Surgical Oncology, Division of Surgery

Present Title & Affiliation

Primary Appointment

Hepato-Pancreato-Biliary Surgery Fellowship Associate Program Director, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Assistant Professor, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Assistant Professor, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2010	Jefferson Medical College, Philadelphia, Pennsylvania, US, MD
2006	Colgate University, Hamilton, New York, US, Bachelor of Arts, BA

Postgraduate Training

2019-2020	Hepatopancreatobiliary Surgery Fellowship, The University of Texas MD Anderson Cancer Center, Houston, Texas
2017-2019	Complex General Surgery Fellowship, The University of Texas MD Anderson Cancer Center, Houston, Texas
2016-2017	Residency, Administrative Chief Resident, University of Virginia Health System, Charlottesville, Virginia
2012-2014	Research Fellowship, T32, University of Virginia Health System, Charlottesville, Virginia
2011-2017	General Surgery Residency, General Surgery, University of Virginia Health System, Charlottesville, Virginia
2010-2011	General Surgery Internship, General Surgery, University of Virginia Health System, Charlottesville, Virginia

Licenses & Certifications

2023	Medical License/Mississippi State Board of Medical Licensure
2023	Medical License/Oklahoma State Board of Medical Licensure
2023	Medical Licensure/Georgia Composite Medical Board
2023	Medical License/Louisiana State Board of Medical Examiners
2023	Medical License/Alabama Board of Medical Examiners
2023	Medical License/Tennessee Board of Medical Examiners
2023	Medical License/Washington State Department of health
2023	Medical License/Arizona Board of Medical Examiners
2020	Complex General Surgical Oncology
2017	American Board of Surgery
2017	Texas

Experience & Service

Faculty Academic Appointments

Hepato-Pancreato-Biliary Surgery Fellow and Clinical Specialist, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2020

Surgical Oncology Fellow and Clinical Specialist, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2019

Clinical Specialist, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2020

General Surgery Resident, Department of Surgery, University of Virginia Health System, Charlottesville, VA, 2010 - 2017

Administrative Appointments/Responsibilities

Associate Patient Safety Quality Officer, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present

MDACC Division of Surgery Fellow’s Clinical Trials Course Associate- Director, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - 2025

IMD for P10/ Surgical Oncology CRS, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 2024 - Present

Hepato-Pancreato-Biliary Surgery Fellowship Associate Program Director, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present

HPB Section Education Co-Lead, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present

Administrative Chief Resident, Department of Surgery, University of Virginia Health System, Charlottesville, VA, 2016 - 2017

Extramural Institutional Committee Activities

Member, Unified Biliary Track (Clinical) Committee, Digestive Disease Week (DDW), 2025 - 2026

Member, WSA Young Surgeons Committee, Western Surgical Association (WSA), 2025 - 2024

Member, Society for Surgery of the Alimentary Tract Education Committee, Society for Surgery of the Alimentary Tract, 2024 - Present

Committee Member, AHPBA Clinical Trials Committee, The Americas Hepato-Pancreato-Biliary Association (AHPBA), 2024 - Present

Member, IHPBA Social Media Committe, International Hepato-Pancreato-Biliary Association (IHPBA), 2023 - Present

Chair, Communications Committee, Western Surgical Association (WSA), 2022 - Present

Member-Early Career Group, International Hepato-Billiary Association (IHPBA), IHPBA, 2022 - Present

Early Career Surgeon's Working Group, Education Committee of the SSAT, Society for Surgery of the Alimentary Tract, 2022 - 2026

Member, Society for Surgery of the Alimentary Tract (SSAT), SSAT, 2022 - 2023

Member, INTERCEPT Circulating Tumor DNA for Colorectal Cancer Program, The University of Texas MD Anderson Cancer Center, 2022 - Present

Member, Program Committee/Annual Meeting 2022, South Texas American College of Surgeons (ST-ACS), ST-ACS, 2022

Member, CGSO Fellow Application Review Committee (FARC), The University of Texas MD Anderson Cancer Center, 2021 - Present

Member, Pharmacy and Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present

Alternate member, Pain Task Force/Pain Management Subcommittee, The University of Texas MD Anderson Cancer Center, 2021 - Present

Leader, Met Colorectal Cancer 60 Minutes Research Club, The University of Texas MD Anderson Cancer Center, 2021 - Present

Member, Surgical Oncology Research Oversight Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present

Editorial Activities

Editorial Board Member, Journal of Surgical Oncology, 2026 - Present

Editorial Board Member, Annals of Surgical Oncology (ASO), 2023 - 2026

Honors & Awards

2025 - Present	Top 1% of Providers Nationally Ranked by Patients for their Delivery of Care, The University of Texas MD Anderson Cancer Center
2025 - Present	Patient Experience Recognition, The University of Texas MD Anderson Cancer Center
2025 - Present	Patient Experience Recognition, The University of Texas MD Anderson Cancer Center
2025 - Present	Surgical Oncology Fellowship Department of Surgical Oncology Teaching Excellence, The University of Texas MD Anderson Center
2023 - 2025	2023-2025 class of the AHPBA Academy, Americas Hepato-Pancreato-Biliary Association
2023	Physicians Referral Service Top Performer Award, MD Anderson, Consumer Assessment of Healthcare Providers and Systems
2023	J. Bradley Aust Award for Best Presentation by a New Member, Western Surgical Association
2023	International Junior Surgeon Travel Exchange, The Society for Surgery of the Alimentary Tract
2020	The Charles Balch Clinical Research Award, Surgical Oncology Fellowship, The University of Texas MD Anderson Cancer Center
2019	The Marion D. Edwards Fellowship in Hepatic Oncology, Trainee Research Day, The University of Texas MD Anderson Cancer Center
2019	First Place, Trainee Research Day Oral Competition, The University of Texas MD Anderson Cancer Center
2019	First Place, Cancer Survivorship Abstract Competition, Trainee Research Day, The University of Texas MD Anderson Cancer Center
2017	Nominee, All University Award for Teaching, University of Virginia
2017	Humanism and Excellence in Teaching Award, University of Virginia School of Medicine
2017	Hugh Shepherd Warren, M.D. Chief Resident of the Year Award, University of Virginia Department of Surgery
2017	Gold Humanism Honor Society, UVA Chapter, University of Virginia School of Medicine
2016	Trauma Chief Resident of the Year, University of Virginia Departments of Surgery and Emergency Medicine
2016	Third Place Oral Presentation, 15th Annual University of Virginia Department of Surgery Resident Research Day
2014	Finalist, Best Basic Science Poster, Society of Surgical Oncology Poster Competition, 67th Annual Cancer Symposium
2014	Best Basic Science Manuscript, Annual Resident/Fellow Essay Award, 67th Annual Society of Surgical Oncology Annual Cancer Symposium
2014	First Place Oral Presentation, 13th Annual University of Virginia Department of Surgery Resident Research Day
2013	Scholar-in-Training Award, American Association for Cancer Research Special Conference on the Translational Impact of Model Organisms in Cancer
2012	Mulholland Society Distinguished Resident Educator Award, University of Virginia School of Medicine
2010	The Dean's Student Service Award, Honorable Mention, Class day exercises, Jefferson Medical College
2010	The Philip J. Wolfson, MD Memorial Prize for Leadership, Class Day Exercises, Jefferson Medical College
2010	Alpha Omega Alpha, Jefferson Medical College
2010	The Francis Torrens Stewart, M.D. Clinical Surgery Prize for Leadership, Class Day Exercises, Jefferson Medical College
2009	John H. Gibbon Jr., MD Annual Grand Rounds Speaker Selection, Thomas Jefferson University Hospital, Department of Surgery
2008	Excellence in Professionalism Award, Jefferson Medical College
2008	Hobart Amory Hare Medical Honor Society, Jefferson Medical College
2006	Honors, Molecular Biology, Colgate University
2005	Phi Beta kappa Liberal Arts and Sciences Academic Honor Society, Colgate University
2004	Beta Beta Beta Biological Sciences Honor Society, Upsilon Phi Chapter, Colgate University
2002	Phi Eta Sigma National Honor Society, Colgate University
2002 - 2006	Dean's Award for Academic Excellence, Colgate University
	Perfect Score Providers, The University of Texas MD Anderson Cancer Center

Professional Memberships

Western Surgical Society

2021 - Present

International Hepato-Pancreato-Biliary Association

2020 - Present

American Association for Cancer Research

2017 - 2020

Society for Surgery of the Alimentary Tract

2017 - Present

The Americas Hepato-Pancreato-Biliary Association

2015 - Present

Society of Surgical Oncology

2012 - Present

American College of Surgeons

2010 - Present

Selected Presentations & Talks

Local Presentations

2025. Keep Pushing Forward: Pathways in HPB Surgical Care at MD Anderson Cancer Center. Invited. NASOG Alumni Symposium. Houston, Texas, US.
2025. Optimizing Surgical Outcomes. Invited. NASOG Alumni Symposium. Houston, Texas, US.
2025. MJKSS Virtual Alumni Speaker Series. Invited. Charlottesville, Virginia, US.
2025. CTDNA and CLM - A Surgeons Perspective. Invited. Cancer Center Support Grant Gastrointestinal Cancer Program 2025 Annual Research Retreat Agenda. Houston, Texas, US.
2024. Surgical Perspective of Managing Cholangiocarcinoma and Liver Transplant. Invited. 5th Annual Sawyer International Pancreato-Biliary and Gastrointestinal Cancer Symposium. Houston, TX, US.
2024. Idea to SIV: Timeline for Your First Trial as Faculty. Poster. DoS Trials Course. Houston, Texas, US.
2023. Idea to SIV: Timeline for Your First Trial as Faculty. Poster. DoS Trials Course. Houston, Texas, US.
2022. Role of surgery in management of advanced disease. Conference. Role of surgery in management of advanced disease. Houston, TX, US.
2022. Targeted therapy and liver translation outcome. Conference. Targeted therapy and liver translation outcome. Houston, TX, US.
2020. ct DNA and CLM: Where we are now and where we are going (or can go...). Conference. Houston, TX, US.
2019. Clinical factors associated with practice variation in discharge opioid prescriptions after pancreatectomy. Conference. Clinical factors associated with practice variation in discharge opioid prescriptions after pancreatectomy, US.
2019. Clinical factors associated with practice variation in discharge opioid prescriptions after pancreatectomy. Conference. Clinical factors associated with practice variation in discharge opioid prescriptions after pancreatectomy. Houston, TX, US.
2018. Opioid Use and Prescription Patterns Following Oncologic Surgery. Conference. Opioid Use and Prescription Patterns Following Oncologic Surgery. Houston, TX, US.

Regional Presentations

2017. Occult metastatic pancreatic cancer cells stimulate an innate immune response in the liver microenvironment. Conference. Occult metastatic pancreatic cancer cells stimulate an innate immune response in the liver microenvironment. Williamsburg, VA, US.
2017. Teams need opponents: surgeon scientists and pancreatic cancer. Conference. Teams need opponents: surgeon scientists and pancreatic cancer, US.
2016. Resident Liver Macrophages Suppress Outgrowth of Occult Liver Metastases and Prolong Survival in a Preclinical Mouse Model of Pancreatic Cancer. Conference. Resident Liver Macrophages Suppress Outgrowth of Occult Liver Metastases and Prolong Survival in a Preclinical Mouse Model of Pancreatic Cancer. Charlottesville, VA, US.
2014. A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest. Conference. A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest. Nellysford, VA, US.
2014. A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest. Conference. A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest. Charlottesville, VA, US.
2013. DUSP6 expression reflects RAS pathway activation and growth rate in pancreatic cancer cells after MEK1/2 inhibition. Conference. DUSP6 expression reflects RAS pathway activation and growth rate in pancreatic cancer cells after MEK1/2 inhibition. Virginia Beach, VA, US.
2013. Bowel preparation for Pancreaticoduodenectomy is associated with higher risks and no benefit. Conference. Bowel preparation for Pancreaticoduodenectomy is associated with higher risks and no benefit. Virginia Beach, VA, US.
2013. DUSP6 expression reflects RAS pathway activation and growth rate in pancreatic cancer cells after MEK1/2 inhibition. Conference. DUSP6 expression reflects RAS pathway activation and growth rate in pancreatic cancer cells after MEK1/2 inhibition. Charlottesville, VA, US.
2012. Distal pancreatectomy with minimal blood loss is associated with markedly improved outcomes – an ACS NSQIP analysis. Conference. Distal pancreatectomy with minimal blood loss is associated with markedly improved outcomes – an ACS NSQIP analysis. Falls Church, VA, US.

National Presentations

2026. Evolving Role of Circulating Tumor DNA (ctDNA) Assays of MRD- Colorectal Cancer. Invited. 22nd Oncology Updates: Advances and Controversies. Steamboat Springs, Colorado, US.
2025. Value and Innovation in Robotic Surgery for Patients with Cancer. Invited. 2025 ACS Annual Meeting. Chicago, Illnois, US.
2025. Evolving role for circulating tumor DNA (ctDNA). Invited. 21st Oncology Updates: Advances and Controversies. Steamboat Springs, CO, US.
2024. Surgical considerations for perihilar cholangiocarcinoma. Invited. Houston Cholangiocarcinoma Symposium. Houston, TX, US.
2024. Computer-Assisted Surgery and Biology. Invited. 2024 AHPBA Annual Meeting. Miami, Florida, US.
2024. How should we use ctDNA to Treat Patients with Advanced Colon and Pancreatic Cancer?. Invited. 2024 Society of Surgical Oncology (SSO) Annual Meeting. Atlanta, Georgia, US.
2024. Trials in Motion for Colorectal Liver Mets. Conference. 2024 Society of Surgical Oncology (SSO) Annual Meeting. Atlanta, Georgia, US.
2024. Circulating Tumor DNA in Colon Cancer. Conference. 20th Oncology Update: Advances and Controversies MD Anderson Cancer Center. Steamboat Springs, CO, US.
2023. Role of Genomics for HCC and iCCA. Conference. HOUSTON METHODIST J.C. WALTER JR CONFERENCE SERIES. Houston, TX, US.
2023. What is the Role of IR Locoregional Therapy for mCRC. Invited. Boston, MA, US.
2022. Invited Discussant, Patient derived xenograft growth reliably predicts recurrence and survival in surgically resected pancreaticobiliary cancers. Conference. Western Surgical Association Meeting. Santa Barbara, CA, US.
2022. Tumor Genomic Profiling in Colorectal Cancer. Invited. ACS Clinical Congress 2022. San Diego, CA, US.
2021. Virtual Invited speaker - Resident and Fellow Workshop: Careers and Fellowships in GI Surgery. Conference. SSAT Webinars, US.
2020. Minimally-invasive approaches to biliary tract cancers and nodal sampling: not all approaches are similar. Conference. Minimally-invasive approaches to biliary tract cancers and nodal sampling: not all approaches are similar. Miami Beach, FL, US.
2020. Neoadjuvant treatment mitigates the survival impact of major complications after resection of pancreatic adenocarcinoma. Conference. Neoadjuvant treatment mitigates the survival impact of major complications after resection of pancreatic adenocarcinoma. Miami Beach, FL, US.
2019. Opioid prescribing practices following major oncologic surgery: a single-center experience. Conference. Opioid prescribing practices following major oncologic surgery: a single-center experience. Washington, DC, US.
2019. Opioid prescribing patterns after hepatectomy: opportunities for minimizing variation and dissemination. Conference. Opioid prescribing patterns after hepatectomy: opportunities for minimizing variation and dissemination. Miami Beach, FL, US.
2019. Early measurement of drain amylase predicts development of postoperative pancreatic fistula in risk-stratified patients following pancreatectomy. Conference. Early measurement of drain amylase predicts development of postoperative pancreatic fistula in risk-stratified patients following pancreatectomy. Miami Beach, FL, US.
2019. Variation in contemporary perioperative opioid prescribing practices in surgical oncology. Conference. Variation in contemporary perioperative opioid prescribing practices in surgical oncology. San Diego, CA, US.
2017. Blood loss and blood transfusion are significant predictors of hospital length of stay and long-term survival in patients undergoing pancreatectomy. Conference. Blood loss and blood transfusion are significant predictors of hospital length of stay and long-term survival in patients undergoing pancreatectomy. Miami Beach, FL, US.
2015. Adjuvant sequential gemcitabine followed by trametinib inhibits outgrowth of occult liver metastases and prolongs survival after pancreatic cancer resection: results from a randomized preclinical trial with patient-derived tumors. Conference. Adjuvant sequential gemcitabine followed by trametinib inhibits outgrowth of occult liver metastases and prolongs survival after pancreatic cancer resection: results from a randomized preclinical trial with patient-derived tumors. Houston, TX, US.
2015. The result of surgeon aging on patient selection and surgical outcomes. Conference. The result of surgeon aging on patient selection and surgical outcomes. Las Vegas, NV, US.
2014. Morbidity and mortality of pancreaticoduodenectomy for premalignant pancreatic neoplasms. Conference. Morbidity and mortality of pancreaticoduodenectomy for premalignant pancreatic neoplasms. New York, NY, US.
2014. Morbidity and mortality of hepatectomy for benign liver tumors. Conference. Morbidity and mortality of hepatectomy for benign liver tumors. New York, NY, US.
2014. A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest. Conference. A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest. Phoenix, AZ, US.

International Presentations

2025. PAM-HBP Surgery 2025: Precision Anatomy for Biliary Diseases - From Cholecystitis to Perihilar Cholangiocarcinoma. Panelist, US.
2024. ctDNA and colorectal liver metastases: More than a biomarker. Invited. 35th IASGO World Congress. Cairo, EG.
2024. “Somatic and Circulating Mutational Profiling for Colorectal Liver Metastases: Prognosis and Patient Selection for Hepatectomy. Visiting, DE.
2024. Survival Improvement over Time in Patients with Young-Onset Colorectal Cancer with Resected Synchronous Liver Metastases. Invited. 16th World Congress of the IHPBA. Cape Town, ZA.
2024. Prognostic Value of ctDNA in Colorectal Liver Mets. Invited. 16th World Congress of IHPBA. Cape Town, ZA.
2024. Parenchymal-Sparing Hepatectomy Is Associated with a Higher Rate of Positive Margins than Single-Stage Major Hepatectomy but Not Higher Recurrence Rate in Patients with Five or More Bilateral Colorectal Liver Metastases. Invited. 16th World Congress of the IHPBA. Cape Town, ZA.
2024. Dynamics of ctDNA for Post Operative Risk Stratification. Conference. Dynamics of ctDNA for Post Operative Risk Stratification. San Juan, PR.
2024. Liver Resection in the Era of TNT and Non-operative Management of the Rectal Primary. Conference. Liver Resection in the Era of TNT and Non-operative Management of the Rectal Primary. San Juan, PR.
2023. When do I use molecular profiling and ctDNA in CRLM?. Conference. When do I use molecular profiling and ctDNA in CRLM?, DE.
2023. Liquid biopsy and ctDNA – where do we stand?. Conference. Liquid biopsy and ctDNA – where do we stand?, DE.
2023. Clinical and Research updates from HPB section at MDACC. Invited. Rheingoldhalle Mainz, DE.
2023. Genetics and markers in selection of oncological patients. Invited. 2023 Joint International Congress of ILTS, ELITA & LICAGE. Rotterdam, NL.
2019. Metastatic well-differentiated neuroendocrine tumor. Conference. Metastatic well-differentiated neuroendocrine tumor. Houston, US.

Less

Grant & Contract Support

Date:	2023 - 2026
Title:	The Gut Microbiome and the Tumor Microenvironment’s Association with Minimal Residual Disease in Liver and Peritoneal Metastases from Colorectal Cancer
Funding Source:	The University of Texas MD Anderson Cancer Center Institutional Research Grant, CSF
Role:	PI

Date:	2021 - 2023
Title:	Risk‐Stratified Adjuvant Therapy: ctDNA‐Directed Post‐Hepatectomy Chemotherapy For Patients With Resectable Colorectal Liver Metastases
Funding Source:	MD Anderson Cancer Center SPORE in Gastrointestinal Cancer Career Enhancement Program Research Award
Role:	PI

Date:	2012 - 2014
Title:	Occult metastases in pancreatic cancer: employing a murine xenograft model of liver metastases to identify factors regulating metastatic cell proliferation
Funding Source:	NIH/NCI
Role:	Research Fellow

Title:	ctDNA-Directed Chemotherapy After Hepatectomy for Colorectal Liver Metastases ( NCT05062317)
Funding Source:	UTMDACC GI SPORE Career Enhancement Program
Role:	PI
ID:	FP00013675

Title:	Preoperative Yttrium-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients with Colorectal Liver Metastases (NCT05062317)
Funding Source:	Sirtex
Role:	Co-PI

Selected Publications

Peer-Reviewed Articles

Joliat, GR, Chevallier, P, Wigmore, SJ, Martin, D, Labgaa, I, Uldry, E, Halkic, N, Newhook, TE, Haddad, A, Vauthey, JN, Memeo, R, Dasari, BV, Braunwarth, E, Brustia, R, Sommacale, D, Rodda, GA, Kobeiter, H, Duran, R, Denys, A, Demartines, N, Melloul, E. First results from the international registry on liver venous deprivation (EuroLVD). HPB 27(8):1020-1027, 2025. e-Pub 2025. PMID: 40350358.
Acidi B, Haddad A, Newhook TE, Ikoma N, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. Advancing Robotic Liver Resection: The Sling Technique for Improved Hepatic Retraction. Ann Surg Oncol 32(7):5021, 2025. e-Pub 2025. PMID: 40126718.
Chirban AM, Rivera B, Kawahara W, Mellado S, Niakosari M, Okuno M, Panettieri E, De Bellis M, Kristjanpoller W, Merlo I, Serenari M, Donadon M, Newhook TE, de Aretxabala X, Vivanco M, Brudvik KW, Seo S, Pekolj J, Poultsides GA, De Rose AM, Torzilli G, Giuliante F, Denbo J, Anaya DA, Vinuela E, Tzeng CD, Vauthey JN, Ruzzenente A, Vega EA. Advanced gallbladder cancer (T3 and T4): insights from an international multicenter study. J Gastrointest Surg 29(7):102080, 2025. e-Pub 2025. PMID: 40449084.
Lendoire M, Maki H, Haddad A, Jain AJ, Tran Cao HS, Chun YS, Tzeng CD, Vauthey JN, Newhook TE. Parenchymal-sparing hepatectomy vs single-stage major hepatectomy for bilateral colorectal liver metastases: a higher rate of microscopically positive margins is not associated with increased local recurrence after parenchymal-sparing hepatectomy. J Gastrointest Surg 29(7):102070, 2025. e-Pub 2025. PMID: 40280465.
Serenari M, Berti D, Rivera B, Newhook TE, Kristjanpoller W, Ruzzenente A, Okuno M, De Bellis M, Panettieri E, Ahmad MU, Merlo I, De Rose AM, Nishino H, Sinnamon AJ, Donadon M, Hauger MS, Guevara OM, Munoz C, Denbo J, Chun YS, Cao HST, Claria RS, Tzeng CD, de Aretxabala X, Vivanco M, Brudvik KW, Seo S, Pekolj J, Poultsides GA, Anaya DA, Torzilli G, Giuliante F, Guglielmi A, Vinuela E, Vauthey JN, Cescon M, Vega EA. ASO Visual Abstract: Optimizing Outcomes in Gallbladder Cancer: Identifying Predictors of Futile Up-Front Surgery in a Global Multi-Center Study. Ann Surg Oncol 32(6):4374-4382, 2025. e-Pub 2025. PMID: 40050485.
Perri, G, Di, MM, Minter, R, Srinivasa, S, Newhook, TE, Roch, A, Guest, R, Fretland, ÅA, Prodehl, L, Thepbunchonchai, A, Hallet, J. Challenges in early career for HPB surgeons an international practice survey. HPB 27(6):771-779, 2025. e-Pub 2025. PMID: 40024851.
Jain AJ, Lendoire M, Haddad A, Tzeng CD, Boyev A, Maki H, Chun YS, Arvide EM, Lee S, Hu I, Pant S, Javle M, Tran Cao HS, Vauthey JN, Newhook TE. Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma: A 27-Year Experience. Ann Surg Oncol 32(6):4352-4362, 2025. e-Pub 2025. PMID: 40000564.
Jain AJ, Haddad A, Newhook TE. ASO Author Reflections: Perihilar Cholangiocarcinoma-Optimizing Outcomes. Ann Surg Oncol 32(6):4427-4428, 2025. e-Pub 2025. PMID: 40111632.
Fields BC, Newhook TE, Lillemoe HA, Maxwell JE, Soliz JM, Popat KU, Roland CL, Vauthey JN, Katz MHG, Tzeng CD. Persistent Improvement in Opioid Perceptions and Prescribing for Cancer Surgery: 5-Year Follow-Up. Adv Cancer Educ Qual Improv 1(1):15, 2025. e-Pub 2025. PMID: 40453772.
Fields BC, Soliz JM, Speer BB, Hancher-Hodges S, Popat KU, Ghebremichael SJ, Van Meter A, Williams UU, Wang X, Hwang H, Bruno ML, Dewhurst WL, Arvide EM, Ikoma N, Maxwell JE, Kim MP, Katz MHG, Tzeng CD, Newhook TE. Repeat versus Single Quadratus Lumborum Block to Reduce Opioids After Open Pancreatectomy (RESQU-BLOCK): A Randomized Clinical Trial. Ann Surg, 2025. e-Pub 2025. PMID: 40421798.
Odisio, BC, Albuquerque, J, Lin, YM, Anderson, BM, OConnor, C, Rigaud, B, Briones-Dimayuga, M, Jones, AK, Fellman, B, Huang, SY, Kuban, JD, Metwalli, ZA, Sheth, RA, Habibollahi, P, Patel, MN, Shah, KY, Cox, V, Kang, HC, Morris, VK, Kopetz, S, Javle, M, Kaseb, A, Tzeng, CW, Cao, HT, Newhook, TE, Chun, YS, Vauthey, JN, Gupta, S, Paolucci, I, Brock, K. Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL) a randomised phase 2 trial. The Lancet Gastroenterology and Hepatology 10(5):442-451, 2025. e-Pub 2025. PMID: 40090348.
Maki H, Ayabe RI, Haddad A, Nishioka Y, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, Vauthey JN. ASO Visual Abstract: Associations of KRAS Point Mutations with Survival in Patients who Underwent Curative-Intent Resection of Colorectal Liver Metastases. Ann Surg Oncol 32(5):3566-3567, 2025. e-Pub 2025. PMID: 39976846.
White MG, Ayabe RI, Zeineddine MA, Zeineddine FA, Yousef AMG, Yousef M, Galbraith NJ, Iorgulescu JB, Scally C, Fournier K, Newhook TE, You NY, Willis J, Kopetz S, Chang GJ, Shen JP, Uppal A. Tumoral and circulating genomic landscape inform survival differences in colorectal carcinomatosis. Transl Oncol 55:102379, 2025. e-Pub 2025. PMID: 40184716.
Fields BC, Newhook TE, Prakash LR, Arvide EM, Li Z, Tran Cao HS, Maxwell JE, Perrier ND, Katz MH, Vauthey JN, Tzeng CD. Impact of Nonhepatectomy Opioid Reduction Efforts on Posthepatectomy Opioid Prescription: Analysis of 2,005 Patients. J Am Coll Surg 240(4):474-487, 2025. e-Pub 2025. PMID: 39807798.
Maki H, Ayabe RI, Haddad A, Nishioka Y, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, Vauthey JN. Associations of KRAS Point Mutations with Survival of Patients Who Underwent Curative-Intent Resection of Colorectal Liver Metastases. Ann Surg Oncol 32(4):2425-2434, 2025. e-Pub 2025. PMID: 39821490.
Jain AJ, Lendoire M, Haddad A, Tzeng CD, Boyev A, Maki H, Chun YS, Arvide EM, Lee S, Hu I, Pant S, Javle M, Tran Cao HS, Vauthey JN, Newhook TE. ASO Visual Abstract: Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma-A 27-Year Experience. Ann Surg Oncol 32:4445–4446, 2025. e-Pub 2025. PMID: 40131623.
Serenari M, Berti D, Rivera B, Newhook TE, Kristjanpoller W, Ruzzenente A, Okuno M, De Bellis M, Panettieri E, Ahmad MU, Merlo I, De Rose AM, Nishino H, Sinnamon AJ, Donadon M, Hauger MS, Guevara OM, Munoz C, Denbo J, Chun YS, Tran Cao HS, Sanchez Claria R, Tzeng CD, De Aretxabala X, Vivanco M, Brudvik KW, Seo S, Pekolj J, Poultsides GA, Anaya DA, Torzilli G, Giuliante F, Guglielmi A, Vinuela E, Vauthey JN, Cescon M, Vega EA. Optimizing Outcomes in Gallbladder Cancer: Identifying Predictors of Futile Up-Front Surgery in a Global Multi-center Study. Ann Surg Oncol, 2025. e-Pub 2025. PMID: 40050485.
Haddad A, Khavandi MM, Lendoire M, Acidi B, Chiang YJ, Gupta S, Tam A, Odisio BC, Mahvash A, Abdelsalam ME, Lin E, Kuban J, Newhook TE, Tran Cao HS, Tzeng CD, Huang SY, Vauthey JN, Habibollahi P. Propensity Score-Matched Analysis of Liver Venous Deprivation and Portal Vein Embolization Before Planned Hepatectomy in Patients with Extensive Colorectal Liver Metastases and High-Risk Factors for Inadequate Regeneration. Ann Surg Oncol 32(3):1752-1761, 2025. e-Pub 2025. PMID: 39633174.
Seo YD, Acidi B, Newton A, Haddad A, Chiang YJ, Coelho R, Newhook TE, Tzeng CD, Chun YS, Ludmir EB, Koay EJ, Javle M, Vauthey JN, Cao HST. Defining the Role of Adjuvant Radiotherapy for Biliary Tract Cancers: A Site-Specific Propensity-Matched Analysis. Cancers (Basel) 17(3), 2025. e-Pub 2025. PMID: 39941861.
White, MG, Zeineddine, MA, Fallon, EA, Zeineddine, F, Dansby, J, Chowdhury, S, Hornstein, N, Yousef, A, Yousef, M, Bhutiani, N, Gu, Y, Kee, BK, Dasari, NV, Overman, MJ, Raghav, KS, Kopetz, S, Uppal, A, Taggart, MW, Newhook, TE, Fournier, KF, Helmink, BA, Drusbosky, L, Shen, JY. The Landscape of ctDNA in Appendiceal Adenocarcinoma. Clinical Cancer Research 31(3):551-560, 2025. e-Pub 2025. PMID: 39679931.
Haddad A, Lendoire M, Uppal A, Maki H, Folkert I, Wang Y, Ayabe RI, Newhook TE, Chun YS, Tzeng CD, Vauthey JN, Tran Cao HS. CEA Rebound After Discontinuation of Pre-Hepatectomy Chemotherapy Predicts Worse Outcomes After Resection of Colorectal Cancer Liver Metastases. Ann Surg Oncol 32(2):1021-1032, 2025. e-Pub 2025. PMID: 39516416.
Landry J, Jain AJ, Tzeng CW, Newhook TE, Ikoma N, Chun YS, Vauthey JN, Cheah YL, Hawksworth JS, Tran Cao HS. Robotic Hepatic Parenchymal Transection Techniques: A Choice Between Imperfect Tools. Ann Surg Oncol 32(1):438-439, 2025. e-Pub 2025. PMID: 39414702.
Fields BC, Newhook TE, Lillemoe HA, Qiao W, Karam JA, Matin SF, Meyer LA, Tzeng CD. 5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Randomized Clinical Trial Protocol. Adv Cancer Educ Qual Improv 1(1), 2025. e-Pub 2025. PMID: 40583965.
Smits, J, Chau, S, James, S, Korenblik, R, Tschögl, M, Arntz, P, Bednarsch, J, Abreu de Carvalho, L, Detry, O, Erdmann, J, Gruenberger, T, Hermie, L, Neumann, U, Sandstrom, P, Sutcliffe, RP, Denys, A, Melloul, E, Dewulf, M, van der Leij, C, van Dam, RM, Chevallier, P, Wigmore, SJ, Newhook, TE, Vauthey, JN, Memeo, R, Dasari, BV, Braunwarth, E, Aldrighetti, L, Andorrà, EC, Arslan, B, van Baardewijk, L, Baclija, I, Ball, CG, Barbier, L, Bemelmans, M, Bent, C, van den Bergh, F, Billingsley, K, Binkert, CA, Björnsson, B, de Boer, MT, Bokkers, RP, de Boo, D, Garcia Borobia, FJ, Braat, D, Breen, D, Breitenstein, S, Brousseau, K, Bruijnen, RC, Bruners, P. Combined portal and hepatic vein embolisation in perihilar cholangiocarcinoma. HPB 26(12):1458-1466, 2024. e-Pub 2024. PMID: 39277435.
Boyev A, Popat K, Gottumukkala VNR, Kwater AP, Chiang YJ, Prakash LR, Newhook TE, Arvide EM, Dewhurst WL, Bruno ML, Van Meter A, Hancher-Hodges S, Ghebremichael S, Williams U, Donahue H, Soliz J, Tzeng CD. Postoperative pain scores and opioid use after standard bupivacaine vs. liposomal bupivacaine regional blocks for abdominal cancer surgery: A propensity score matched study. Am J Surg 237:115770, 2024. e-Pub 2024. PMID: 38789322.
Azimuddin AM, Hirata Y, Boyev A, Jain AJ, Ayabe R, Ajith J, Schmeisser JA, Newhook TE, Ikoma N, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. A propensity score matched cost analysis of robotic versus open hepatectomy. HPB (Oxford) 26(11):1379-1386, 2024. e-Pub 2024. PMID: 39198140.
De B, Dogra P, Zaid M, Elganainy D, Sun K, Amer AM, Wang C, Rooney MK, Chang E, Kang HC, Wang Z, Bhosale P, Odisio BC, Newhook TE, Tzeng CD, Cao HST, Chun YS, Vauthey JN, Lee SS, Kaseb A, Raghav K, Javle M, Minsky BD, Noticewala SS, Holliday EB, Smith GL, Koong AC, Das P, Cristini V, Ludmir EB, Koay EJ. Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response. medRxiv, 2024. e-Pub 2024. PMID: 39314943.
Lendoire, M, Maki, H, Haddad, A, Newhook, TE, Tzeng, CD, Vauthey, JN, Tran Cao, HS. Exceptional pathologic response to preoperative therapy in the context of mutational profiling for colorectal liver metastases. Journal of Gastrointestinal Surgery 28(7):1181-1184, 2024. e-Pub 2024. PMID: 38723997.
Martin AN, Newhook TE, Arvide EM, Kim BJ, Dewhurst WL, Kawaguchi Y, Tran Cao HS, Chun YS, Katz MH, Vauthey JN, Tzeng CD. Utilizing risk-stratified pathways to personalize post-hepatectomy discharge planning: A contemporary analysis of 1,354 patients. Am J Surg 233:17-23, 2024. e-Pub 2024. PMID: 38129274.
Maki, H, Nishioka, Y, Haddad, A, Lendoire, M, Tran Cao, HS, Chun, YS, Tzeng, CD, Vauthey, JN, Newhook, TE. Reproducibility and efficiency of liver volumetry using manual method and liver analysis software. HPB 26(7):911-918, 2024. e-Pub 2024. PMID: 38632032.
Carpenter, EL, Van Decar, SG, McCarthy, PM, Valdera, FA, Adams, AM, O'Shea, AE, Smolinsky, T, Thomas, KK, Clifton, GT, Newhook, TE, Peoples, GE, Nelson, DW, Vreeland, TJ. The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapy. Journal of surgical oncology 130(1):109-116, 2024. e-Pub 2024. PMID: 38801055.
Boyev A, Azimuddin A, Prakash LR, Newhook TE, Maxwell JE, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Lee JE, Snyder RA, Katz MHG, Tzeng CD. Classification of Post-Pancreatectomy Readmissions and Opportunities for Targeted Mitigation Strategies. Ann Surg 279(6):1046-1053, 2024. e-Pub 2024. PMID: 37791481.
Jain AJ, Lendoire M, Boyev A, Newhook TE, Tzeng CD, Tran Cao HS, Coronel E, Lee SS, Hu ZI, Javle M, Lee JH, Vauthey JN, Chun YS. Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress?. Ann Surg Oncol 31(5):3062-3068, 2024. e-Pub 2024. PMID: 38282027.
Maki H, Haddad A, Lendoire M, Newhook TE, Peacock O, Bednarski BK, Konishi T, Vauthey JN, You YN. Evolving survival gains in patients with young-onset colorectal cancer and synchronous resectable liver metastases. Eur J Surg Oncol 50(4):108057, 2024. e-Pub 2024. PMID: 38461567.
Boyev A, Tzeng CD, Maki H, Arvide EM, Mrema DE, Jain AJ, Haddad A, Lendoire M, Malik N, Odisio BC, Chun YS, Tran Cao HS, Vauthey JN, Newhook TE. Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases. Ann Surg Oncol 31(4):2547-2556, 2024. e-Pub 2024. PMID: 38148351.
Boyev A, Arvide EM, Newhook TE, Prakash LR, Bruno ML, Dewhurst WL, Kim MP, Maxwell JE, Ikoma N, Snyder RA, Lee JE, Katz MHG, Tzeng CD. Prophylactic Antibiotic Duration and Infectious Complications in Pancreatoduodenectomy Patients with Biliary Stents: Opportunity for De-Escalation. Ann Surg 279(4):657-664, 2024. e-Pub 2024. PMID: 37389897.
Jain AJ, Newhook TE, Lilley E, Ikoma N, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. A Practical Guide to Inflow Control, Retraction, and Exposure for Robotic Hepatectomy. Ann Surg Oncol 31(3):1833, 2024. e-Pub 2024. PMID: 37989954.
Boyev A, Azimuddin A, Newhook TE, Maxwell JE, Prakash LR, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Snyder RA, Lee JE, Katz MHG, Tzeng CD. Evaluation and Recalibration of Risk-Stratified Pancreatoduodenectomy Drain Fluid Amylase Removal Criteria. J Gastrointest Surg 27(12):2806-2814, 2023. e-Pub 2023. PMID: 37935998.
Adams AM, Vreeland TJ, Newhook TE. Circulating Tumor DNA: Towards More Individualized Treatment for Patients with Resectable Colorectal Cancer. J Gastrointest Cancer 54(4):1071-1081, 2023. e-Pub 2023. PMID: 36562938.
Boyev A, Prakash LR, Chiang YJ, Newhook TE, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Lee JE, Snyder RA, Tzeng CD, Katz MHG, Maxwell JE. Elevated CA 19-9 is associated with worse survival in patients with resected ampullary adenocarcinoma. Surg Oncol 51:101994, 2023. e-Pub 2023. PMID: 37742542.
Boyev A, Jain AJ, Newhook TE, Prakash LR, Chiang YJ, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Maxwell JE, Ikoma N, Snyder RA, Lee JE, Katz MHG, Tzeng CD. Opioid-Free Discharge After Pancreatic Resection Through a Learning Health System Paradigm. JAMA Surg 158(11):e234154, 2023. e-Pub 2023. PMID: 37672236.
Maki H, Kim BJ, Kawaguchi Y, Fernandez-Placencia R, Haddad A, Panettieri E, Newhook TE, Baumann DP, Santos D, Tran Cao HS, Chun YS, Tzeng CD, Vauthey JN, Vreeland TJ. Incidence of and Risk Factors for Incisional Hernia After Hepatectomy for Colorectal Liver Metastases. J Gastrointest Surg 27(11):2388-2395, 2023. e-Pub 2023. PMID: 37537494.
Swords DS, Newhook TE, Tzeng CD, Massarweh NN, Chun YS, Lee S, Kaseb AO, Ghobrial M, Vauthey JN, Tran Cao HS. Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma. Ann Surg Oncol 30(12):7309-7318, 2023. e-Pub 2023. PMID: 37679537.
Boyev A, Prakash LR, Chiang YJ, Childers CP, Jain AJ, Newhook TE, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Lee JE, Snyder RA, Katz MHG, Tzeng CD, Maxwell JE. Postoperative Opioid Use Is Associated with Increased Rates of Grade B/C Pancreatic Fistula After Distal Pancreatectomy. J Gastrointest Surg 27(10):2135-2144, 2023. e-Pub 2023. PMID: 37468733.
Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JN. ASO Author Reflections: The Patient First Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol 30(9):5401-5402, 2023. e-Pub 2023. PMID: 37322282.
Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JN. Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol 30(9):5390-5400, 2023. e-Pub 2023. PMID: 37285096.
Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JN. Correction: Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol 30(9):5405, 2023. e-Pub 2023. PMID: 37344750.
Vega EA, Newhook TE, Mellado S, Ruzzenente A, Okuno M, De Bellis M, Panettieri E, Ahmad MU, Merlo I, Rojas J, De Rose AM, Nishino H, Sinnamon AJ, Donadon M, Hauger MS, Guevara OA, Munoz C, Denbo JW, Chun YS, Tran Cao HS, Sanchez Claria R, Tzeng CD, De Aretxabala X, Vivanco M, Brudvik KW, Seo S, Pekolj J, Poultsides GA, Torzilli G, Giuliante F, Anaya DA, Guglielmi A, Vinuela E, Vauthey JN. Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study. Ann Surg Oncol 30(8):4904-4911, 2023. e-Pub 2023. PMID: 37149547.
Kothari AN, Massarweh NN, Flitcroft MA, Newhook T, Tzeng CD, Chun YS, Kaseb AO, Vauthey JN, Tran Cao HS. Optimizing the future liver remnant: Portal vein embolization, hepatic venous deprivation, and associating liver partition and portal vein ligation for staged hepatectomy. HPB 25(7):758-765, 2023. e-Pub 2023. PMID: 37085394.
Ayabe RI, Prakash LR, Bruno ML, Newhook TE, Maxwell JE, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Snyder RA, Lee JE, Katz MHG, Tzeng CD. Differential Gains in Surgical Outcomes for High-Risk vs Low-Risk Pancreatoduodenectomy with Successive Refinements of Risk-Stratified Care Pathways. J Am Coll Surg 237(1):4-12, 2023. e-Pub 2023. PMID: 36786469.
Ayabe RI, Vauthey JN, Newhook TE. Optimizing the future liver remnant: Portal vein embolization, hepatic venous deprivation, and associating liver partition and portal vein ligation for staged hepatectomy. Surg 174(1):116-118, 2023. e-Pub 2023. PMID: 37024339.
Newhook TE, Overman MJ, Chun YS, Dasari A, Tzeng CD, Cao HST, Raymond V, Parseghian C, Johnson B, Nishioka Y, Kawaguchi Y, Uppal A, Vreeland TJ, Jaimovich A, Arvide EM, Cristo JV, Wei SH, Raghav KP, Morris VK, Lee JE, Kopetz S, Vauthey JN. Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver Metastases. Ann Surg 277(5):813-820, 2023. e-Pub 2023. PMID: 35797554.
Ayabe RI, Paez-Arango N, Estrella JS, Newhook TE, Tzeng CD, Chun YS, Lee S, Javle M, Vauthey JN, Tran Cao HS. Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma - does pathologic response mean better outcomes?. HPB (Oxford) 25(4):472-480, 2023. e-Pub 2023. PMID: 36781357.
Witt RG, Hirata Y, Prakash LR, Newhook TE, Maxwell JE, Kim MP, Tran Cao HS, Lee JE, Vauthey JN, Katz MHG, Tzeng CD, Ikoma N. Comparative analysis of opioid use between robotic and open pancreatoduodenectomy. J Hepatobiliary Pancreat Sci 30(4):523-531, 2023. e-Pub 2023. PMID: 35796581.
Martin AN, Tzeng CD, Arvide EM, Skibber JM, Chang GJ, Nancy You YQ, Bednarski BK, Uppal A, Dewhurst WL, Cristo JV, Chun YS, Tran Cao HS, Vauthey JN, Newhook TE. Impact of cumulative operative time on postoperative complication risk in simultaneous resections of colorectal liver metastases and primary tumors. HPB (Oxford) 25(3):347-352, 2023. e-Pub 2023. PMID: 36697350.
Newhook TE, Vreeland TJ, Griffin JF, Tidwell RSS, Prakash LR, Koay EJ, Ludmir EB, Smaglo BG, Pant S, Overman M, Wolff RA, Ikoma N, Maxwell J, Kim MP, Lee JE, Katz MHG, Tzeng CD. Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma. Ann Surg 277(3):484-490, 2023. e-Pub 2023. PMID: 36649067.
Newhook TE, Uppal A, Synder RA. Mutational Profiling Using Circulating Tumor DNA Helps Guide Treatment Decisions for Patients with Colorectal Cancer 108(3):46-49, 2023. e-Pub 2023.
Paolucci I, Lin YM, Kawaguchi Y, Maki H, Jones AK, Calandri M, Kopetz S, Newhook TE, Brock KK, Vauthey JN, Odisio BC. Targeted exome-based predictors of patterns of progression of colorectal liver metastasis after percutaneous thermal ablation. Br J Cancer 128(1):130-136, 2023. e-Pub 2023. PMID: 36319850.
Martin AN, Concors SJ, Kim BJ, Newhook TE, Arvide EM, Dewhurst WL, Kawaguchi Y, Tran Cao HS, Katz MHG, Vauthey JN, Tzeng CD. Individual components of post-hepatectomy care pathways have differential impacts on length of stay. Am J Surg 225(1):53-57, 2023. e-Pub 2023. PMID: 36207173.
Ikoma N, Seo YD, Newhook TE, Maxwell JE, Kim MP, Tran Cao HS, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Katz MHG. Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. J Hepatobiliary Pancreat Sci 30(1):e1-e2, 2023. e-Pub 2023. PMID: 35950790.
Newton AD, Newhook TE, Ikoma N, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. Robotic Extended Right Hepatectomy for Colorectal Liver Metastasis. Ann Surg Oncol 29(13):8455, 2022. e-Pub 2022. PMID: 36112251.
DiPeri TP, Newhook TE, Prakash LR, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CD. Prognostic significance of preoperative and postoperative CA 19-9 normalization in pancreatic adenocarcinoma treated with neoadjuvant therapy or surgery first. J Surg Oncol 126(6):1021-1027, 2022. e-Pub 2022. PMID: 35726394.
DiPeri TP, Newhook TE, Tran Cao HS, Ikoma N, Dewhurst WL, Arvide EM, Bruno ML, Katz MHG, Vauthey JN, Lee JE, Tzeng CD. Opioid Discharge Prescriptions After Inpatient Surgery: Risks of Rebound Refills by Length of Stay. J Surg Res 278:111-118, 2022. e-Pub 2022. PMID: 35597025.
Kim BJ, Newhook TE, Tzeng CD, Ikoma N, Chiang YJ, Chun YS, Vauthey JN, Tran Cao HS. Lymphadenectomy and margin-negative resection for biliary tract cancer surgery in the United States-Differential technical performance by approach. J Surg Oncol 126(4):658-666, 2022. e-Pub 2022. PMID: 35578764.
Morris VK, Overman MJ, Lam M, Parseghian CM, Johnson B, Dasari A, Raghav K, Kee BK, Huey R, Wolff RA, Shen JP, Li J, Zorrilla I, Tzeng CD, Tran Cao HS, Chun YS, Newhook TE, Vauthey N, Duose D, Luthra R, Haymaker C, Kopetz S. Bintrafusp alfa, an anti-PD-L1:TGF-β trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer. Cancer Res Commun 2(9):979-986, 2022. e-Pub 2022. PMID: 36382087.
Kawaguchi Y, Newhook TE, Fuks D, Cao HST, Tzeng CD, Chun YS, Aloia TA, Gayet B, Vauthey JN. Comment on "Stratification of Major Hepatectomies According to Their Outcome Analysis of 2212 Consecutive Open Resections in Patients Without Cirrhosis". Ann Surg 276(2):e134-e135, 2022. e-Pub 2022. PMID: 33914451.
Newhook TE, Vauthey JN. Colorectal liver metastases: state-of-the-art management and surgical approaches. Langenbecks Arch Surg 407(5):1765-1778, 2022. e-Pub 2022. PMID: 35397680.
Kim BJ, Arvide EM, Gaskill C, Martin AN, Kawaguchi Y, Chiang YJ, Dewhurst WL, Phan TL, Tran Cao HS, Chun YS, Katz MHG, Vauthey JN, Tzeng CD, Newhook TE. Risk-stratified posthepatectomy pathways based upon the Kawaguchi-Gayet complexity classification and impact on length of stay. Surg Open Sci 9:109-116, 2022. e-Pub 2022. PMID: 35747509.
DiPeri TP, Newhook TE, Arvide EM, Dewhurst WL, Bruno ML, Chun YS, Tran Cao HS, Lee JE, Vauthey JN, Tzeng CD. Prospective Implementation of Standardized Post-Hepatectomy Care Pathways to Reduce Opioid Prescription Volume after Inpatient Surgery. J Am Coll Surg 235(1):41-48, 2022. e-Pub 2022. PMID: 35703961.
DiPeri TP, Newhook TE, Day RW, Chiang YJ, Dewhurst WL, Arvide EM, Bruno ML, Scally CP, Roland CL, Katz MHG, Vauthey JN, Chang GJ, Badgwell BD, Perrier ND, Grubbs EG, Lee JE, Tzeng CD, Consortium P. A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients. Surg Open Sci 9:51-57, 2022. e-Pub 2022. PMID: 35663797.
Witt RG, Newhook TE, Prakash LR, Bruno ML, Arvide EM, Dewhurst WL, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CD. Association of Patient Controlled Analgesia and Total Inpatient Opioid Use After Pancreatectomy. J Surg Res 275:244-251, 2022. e-Pub 2022. PMID: 35306260.
Janssen, QP, Van Dam, JL, Prakash, L, Doppenberg, D, Crane, C, van Eijck, CH, Ellsworth, S, Jarnagin, W, O'Reilly, E, Paniccia, A, Reyngold, M, Besselink, MG, Katz, MH, Tzeng, CD, Zureikat, AH, Koerkamp, BG, Wei, A, Nuyttens, JJ, Newhook, TE, Desilva, A, Stoop, TF, Theijse, R. Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma. JNCCN Journal of the National Comprehensive Cancer Network 20(7):783-791, 2022. e-Pub 2022. PMID: 35830887.
Carpenter EL, Valdera FA, Zaman JA, El-Hayek K, Towfigh S, Newhook TE, Nelson DW, Vreeland TJ. Surgical Society Podcasts: A Novel Way to Engage and Educate the Community. J Surg Educ 79(3):565-568, 2022. e-Pub 2022. PMID: 34952817.
Newton AD, Newhook TE, Bruno ML, Prakash L, Chiang YJ, Arango NP, Dewhurst WL, Arvide EM, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CD. Iterative Changes in Risk-Stratified Pancreatectomy Clinical Pathways and Accelerated Discharge After Pancreaticoduodenectomy. J Gastrointest Surg 26(5):1054-1062, 2022. e-Pub 2022. PMID: 35023033.
Mason MC, Krasnodebski M, Hester CA, Kothari AN, Barker C, Nishioka Y, Chiang YJ, Newhook TE, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. ASO Visual Abstract: Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection. Ann Surg Oncol. e-Pub 2022. PMID: 35435560.
Nishioka Y, Chun YS, Overman MJ, Cao HST, Tzeng CD, Mason MC, Kopetz SW, Bauer TW, Vauthey JN, Newhook TE, Program MD. Effect of Co-mutation of RAS and TP53 on Postoperative ctDNA Detection and Early Recurrence after Hepatectomy for Colorectal Liver Metastases. J Am Coll Surg 234(4):474-483, 2022. e-Pub 2022. PMID: 35290266.
Nishioka Y, Paez-Arango N, Boettcher FO, Kawaguchi Y, Newhook TE, Chun YS, Tzeng CD, Tran Cao HS, Lee JE, Vreeland TJ, Vauthey JN. Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases. J Gastrointest Surg 26(4):791-801, 2022. e-Pub 2022. PMID: 34725784.
Witt RG, Cope B, Chiang YJ, Newhook T, Lillemoe H, Tzeng CD, Chen IB, Fisher SB, Lucci A, Wargo JA, Lee JE, Ross MI, Gershenwald JE, Robinson J, Keung EZ. Utilization and evolving prescribing practice of opioid and non-opioid analgesics in patients undergoing lymphadenectomy for cutaneous malignancy. J Surg Oncol 125(4):719-729, 2022. e-Pub 2022. PMID: 34904258.
Oppliger FA, Prakash LR, Newhook TE, Chiang YJ, Ikoma N, Maxwell JE, Kim MP, Vauthey JN, Lee JE, Katz MH, Tzeng CD. AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatment sequencing. Surg Oncol 40:101673, 2022. e-Pub 2022. PMID: 34894620.
Morris, VK, Overman, MJ, Lam, MC, Parseghian, C, Johnson, B, Dasari, NV, Raghav, KS, Kee, BK, Huey, RW, Wolff, RA, Shen, JY, Li, J, Zorrilla, I, Tzeng, CD, Tran Cao, HS, Chun, YS, Newhook, TE, Vauthey, JN, Duose, D, Luthra, R, Haymaker, CL, Kopetz, S. Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer. Cancer Research Communications 2(9):979-986, 2022. e-Pub 2022. PMID: 36382087.
Kawaguchi Y, Newhook TE, Vauthey JN. Comment on "Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases". Ann Surg 274(6):e713-e714, 2021. e-Pub 2021. PMID: 33201092.
Newhook TE, Prakash LR, Soliz J, Hancher-Hodges S, Speer BB, Wilks JA, Bruno ML, Dewhurst WL, Arvide EM, Maxwell JE, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CD. Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therapy. J Surg Oncol 124(8):1381-1389, 2021. e-Pub 2021. PMID: 34398988.
Zaid M, Carapeto F, Dai A, Thunshelle CP, Elganainy D, Sun K, Grassberger C, Kwong LN, Lee S, Newhook T, Tran Cao HS, Vauthey JN, Javle M, Koay EJ. An Imaging Feature From Pre-Therapy Computed Tomography (CT) Scans Correlates With Pathological and the Clinical Outcomes in Patients (Pts) With Intrahepatic Cholangiocarcinoma (iCCA). Int J Radiat Oncol Biol Phys 111(3S):e85, 2021. e-Pub 2021. PMID: 34701984.
Newhook TE, Aloia TA. Guide to Enhanced Recovery for Cancer Patients Undergoing Liver Surgery. Ann Surg Oncol 28(12):6970-6973, 2021. e-Pub 2021. PMID: 33851311.
Chick RC, Adams AM, Peace KM, Kemp Bohan PM, Schwantes IR, Clifton GT, Vicente D, Propper B, Newhook T, Grubbs EG, Bednarski BK, Vreeland TJ. Using the Flipped Classroom Model in Surgical Education: Efficacy and Trainee Perception. J Surg Educ 78(6):1803-1807, 2021. e-Pub 2021. PMID: 34210646.
Newton AD, Newhook TE, Ikoma N, White MG, Tzeng CD, Chun YS, Aloia TA, Vauthey JN, Tran Cao HS. Robotic Completion Radical Cholecystectomy with Fluorescence Guidance. Ann Surg Oncol 28(11):6834, 2021. e-Pub 2021. PMID: 33774771.
Vega EA, Newhook TE, Vauthey JN. ASO Visual Abstract: Conditional Recurrence-Free Survival After Oncologic Extended Resection for Gallbladder Cancer-An International Multicenter Analysis. Ann Surg Oncol 28(7):3695-3696, 2021. e-Pub 2021. PMID: 33939047.
Kim BJ, Newhook TE, Blumenthaler A, Chiang YJ, Aloia TA, Roland CL, Katz MHG, Vauthey JN, Lee JE, Tzeng CD. Sustained reduction in discharge opioid volumes through provider education: Results of 1168 cancer surgery patients over 2 years. J Surg Oncol 124(1):143-151, 2021. e-Pub 2021. PMID: 33751605.
Mason MC, Tzeng CD, Tran Cao HS, Aloia TA, Newhook TE, Overman MJ, Kopetz SE, Vauthey JN, Chun YS. Preliminary Analysis of Liquid Biopsy after Hepatectomy for Colorectal Liver Metastases. J Am Coll Surg 233(1):82-89.e1, 2021. e-Pub 2021. PMID: 33667566.
Kemp Bohan PM, O'Shea AE, Ellis OV, Chick RC, Clem AM, Kirby DT, Bader JO, Newhook TE, Clifton GT, Tzeng CD, Nelson DW, Vreeland TJ. Rates, Predictors, and Outcomes of Portal Lymphadenectomy for Resectable Gallbladder Cancer. Ann Surg Oncol 28(6):2960-2972, 2021. e-Pub 2021. PMID: 33566248.
Vega EA, Newhook TE, Kawaguchi Y, Qiao W, De Bellis M, Okuno M, Panettieri E, Nishino H, Duwe G, Piccino M, De Rose AM, Ruzzenente A, Uemoto S, Vivanco M, Chun YS, Cao HST, Tzeng CD, De Aretxabala X, Seo S, Giuliante F, Guglielmi A, Vinuela E, Vauthey JN. Conditional Recurrence-Free Survival after Oncologic Extended Resection for Gallbladder Cancer: An International Multicenter Analysis. Ann Surg Oncol 28(5):2675-2682. e-Pub 2021. PMID: 33666814.
Newhook TE, Soliz JM, Prakash LR, Hancher-Hodges S, Speer BB, Wilks JA, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CD. Impact of Intraoperative Dexamethasone on Surgical and Oncologic Outcomes for Patients with Resected Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol 28(3):1563-1569, 2021. e-Pub 2021. PMID: 32803553.
Blumenthaler AN, Newhook TE, Ikoma N, Estrella JS, Blum Murphy M, Das P, Minsky BD, Ajani JA, Mansfield PF, Badgwell BD. Concurrent lymphovascular and perineural invasion after preoperative therapy for gastric adenocarcinoma is associated with decreased survival. J Surg Oncol 123(4):911-922, 2021. e-Pub 2021. PMID: 33400838.
Kemp Bohan PM, O'Shea AE, Lee AJ, Chick RC, Newhook TE, Tran Cao HS, Allen CJ, Nelson DW, Clifton GT, Vauthey JN, Tzeng CD, Vreeland TJ. Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes. Surg Oncol 36:138-146, 2021. e-Pub 2021. PMID: 33418464.
Kawaguchi Y, Newhook TE, Tran Cao HS, Tzeng CD, Chun YS, Aloia TA, Dasari A, Kopetz S, Vauthey JN. Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases. J Gastrointest Surg 25(1):186-194, 2021. e-Pub 2021. PMID: 33205306.
Day RW, Newhook TE, Dewhurst WL, Arvide EM, Bruno ML, Vauthey JN, Tzeng CD. Assessing the 5×-Multiplier Calculation to Reduce Discharge Opioid Prescription Volumes After Inpatient Surgery. JAMA Surg 155(12):1166-1167, 2020. e-Pub 2020. PMID: 32997105.
Lillemoe HA, Newhook TE, Aloia TA, Grubbs EG, Chang GJ, Katz MHG, Vauthey JN, Lee JE, Tzeng CD. Perceptions of opioid use and prescribing habits in oncologic surgery: A survey of the society of surgical oncology membership. J Surg Oncol 122(6):1066-1073, 2020. e-Pub 2020. PMID: 32632993.
Kim BJ, Lillemoe HA, Newhook TE, Dewhurst WL, Arvide EM, Katz MHG, Aloia TA, Vauthey JN, Lee JE, Tzeng CD. Educating surgical oncology providers on perioperative opioid use: A departmental survey 1 year after the intervention. J Surg Oncol 122(3):547-554, 2020. e-Pub 2020. PMID: 32447769.
Newhook TE, Vreeland TJ, Dewhurst WL, Wang X, Prakash L, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CD. Clinical Factors Associated With Practice Variation in Discharge Opioid Prescriptions After Pancreatectomy. Ann Surg 272(1):163-169, 2020. e-Pub 2020. PMID: 30499795.
Joechle K, Vreeland TJ, Vega EA, Okuno M, Newhook TE, Panettieri E, Chun YS, Tzeng CD, Aloia TA, Lee JE, Vauthey JN. Anatomic Resection Is Not Required for Colorectal Liver Metastases with RAS Mutation. J Gastrointest Surg 24(5):1033-1039, 2020. e-Pub 2020. PMID: 32162236.
Okuno M, Newhook TE, Joechle K, Kawaguchi Y, De Bellis M, Tzeng CD, Chun YS, Aloia TA, Shindoh J, Kaseb AO, Vauthey JN. Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma?. HPB (Oxford) 22(4):545-552, 2020. e-Pub 2020. PMID: 31533893.
Newhook TE, Vega EA, Vreeland TJ, Prakash L, Dewhurst WL, Bruno ML, Kim MP, Ikoma N, Vauthey JN, Katz MH, Lee JE, Tzeng CD. Early postoperative drain fluid amylase in risk-stratified patients promotes tailored post-pancreatectomy drain management and potential for accelerated discharge. Surgery 167(2):442-447, 2020. e-Pub 2020. PMID: 31727324.
Newhook TE, Vreeland TJ, Dewhurst WL, Arvide EM, Bruno ML, Robinson KA, Rajkot N, Aloia TA, Katz MHG, Vauthey JN, Lee JE, Tzeng CD. Opioid-prescribing Practices After Oncologic Surgery: Opportunities for Improvement and a Call to Action. Ann Surg 271(2):e9-e10, 2020. e-Pub 2020. PMID: 31478982.
Vega EA, De Aretxabala X, Qiao W, Newhook TE, Okuno M, Castillo F, Sanhueza M, Diaz C, Cavada G, Jarufe N, Munoz C, Rencoret G, Vivanco M, Joechle K, Tzeng CD, Vauthey JN, Vinuela E, Conrad C. Comparison of oncological outcomes after open and laparoscopic re-resection of incidental gallbladder cancer. Br J Surg 107(3):289-300, 2020. e-Pub 2020. PMID: 31873948.
Allen CJ, Vreeland TJ, Newhook TE, Das P, Minsky BD, Blum M, Ajani J, Ikoma N, Mansfield PF, Badgwell BD. Prognostic Value of Lymph Node Yield After Neoadjuvant Chemoradiation for Gastric Cancer. Ann Surg Oncol 27(2):534-542, 2020. e-Pub 2020. PMID: 31552618.
Allen CJ, Newhook TE, Vreeland TJ, Das P, Minsky BD, Blum M, Song S, Ajani J, Ikoma N, Mansfield PF, Roy-Chowdhuri S, Badgwell BD. Yield of peritoneal cytology in staging patients with gastric and gastroesophageal cancer. J Surg Oncol 120(8):1350-1357, 2019. e-Pub 2019. PMID: 31612494.
Vicente D, Patino M, Marcus R, Lillemoe H, Limani P, Newhook T, Lee A, Tzeng CW, Segraves-Chun Y, Tweardy D, Gottumukkala V, Vauthey JN, Aloia T, Cata JP. Impact of epidural analgesia on the systemic biomarker response after hepatic resection. Oncotarget 10(59):6397, 2019. e-Pub 2019. PMID: 31695849.
Newhook TE, Dewhurst WL, Vreeland TJ, Wang X, Soliz J, Speer BB, Hancher-Hodges S, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CD. Inpatient Opioid Use After Pancreatectomy: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients. Ann Surg Oncol 26(11):3428-3435, 2019. e-Pub 2019. PMID: 31243665.
Vreeland TJ, Beaudry Simoneau E, Dewhurst WL, Newhook TE, Westin SN, Mehran RJ, Chun YS, Aloia TA, Vauthey JN, Tzeng CD. Intraoperative Air Leak Test to Prevent Bile Leak After Right Posterior Sectionectomy with En Bloc Diaphragm Resection for Metastatic Teratoma. Ann Surg Oncol 26(8):2579, 2019. e-Pub 2019. PMID: 31065963.
Lillemoe HA, Newhook TE, Vreeland TJ, Arvide EM, Dewhurst WL, Grubbs EG, Aloia TA, Vauthey JN, Lee JE, Tzeng CD. Educating Surgical Oncology Providers on Perioperative Opioid Use: Results of a Departmental Survey on Perceptions of Opioid Needs and Prescribing Habits. Ann Surg Oncol 26(7):2011-2018, 2019. e-Pub 2019. PMID: 30937660.
Newhook TE, Agnes A, Blum M, Estrella JS, Das P, Ho L, Ajani JA, Minsky BD, Mansfield P, Badgwell BD. Laparoscopic Hyperthermic Intraperitoneal Chemotherapy is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy. Ann Surg Oncol 26(5):1394-1400, 2019. e-Pub 2019. PMID: 30680477.
Joechle K, Vega EA, Okuno M, Simoneau E, Ogiso S, Newhook TE, Ramirez DL, Holmes AA, Soliz JM, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C. Middle Hepatic Vein Roadmap for a Safe Laparoscopic Right Hepatectomy. Ann Surg Oncol 26(1):296, 2019. e-Pub 2019. PMID: 30465224.
Michaels AD, Newhook TE, Adair SJ, Morioka S, Goudreau BJ, Nagdas S, Mullen MG, Persily JB, Bullock TNJ, Slingluff CL, Ravichandran KS, Parsons JT, Bauer TW. CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer. Clin Cancer Res 24(6):1415-1425, 2018. e-Pub 2018. PMID: 29288236.
Newhook TE, Lindberg JM, Adair SJ, Kim AJ, Stelow EB, Rahma OE, Parsons JT, Bauer TW. Adjuvant Trametinib Delays the Outgrowth of Occult Pancreatic Cancer in a Mouse Model of Patient-Derived Liver Metastasis. Ann Surg Oncol 23(6):1993-2000, 2016. e-Pub 2016. PMID: 26847682.
Guidry CA, Newhook TE, Turrentine FE, Sohn MW, Sawyer RG, Jones RS. Observations on Surgeons' Case Selection, Morbidity, and Mortality Following Board Certification. Ann Surg 263(3):487-92, 2016. e-Pub 2016. PMID: 26372308.
Newhook TE, LaPar DJ, Lindberg JM, Bauer TW, Adams RB, Zaydfudim VM. Morbidity and mortality of hepatectomy for benign liver tumors. Am J Surg 211(1):102-8, 2016. e-Pub 2016. PMID: 26307421.
Newhook TE, LaPar DJ, Walters DM, Gupta S, Jolissaint JS, Adams RB, Brayman KL, Zaydfudim VM, Bauer TW. Impact of Postoperative Venous Thromboembolism on Postoperative Morbidity, Mortality, and Resource Utilization after Hepatectomy. Am Surg 81(12):1216-23, 2015. e-Pub 2015. PMID: 26736156.
Spolverato G, Kim Y, Alexandrescu S, Popescu I, Marques HP, Aldrighetti L, Clark Gamblin T, Miura J, Maithel SK, Squires MH, Pulitano C, Sandroussi C, Mentha G, Bauer TW, Newhook T, Shen F, Poultsides GA, Wallis Marsh J, Pawlik TM. Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration. Ann Surg Oncol 22(7):2218-25, 2015. e-Pub 2015. PMID: 25354576.
Newhook TE, LaPar DJ, Lindberg JM, Bauer TW, Adams RB, Zaydfudim VM. Morbidity and mortality of pancreaticoduodenectomy for benign and premalignant pancreatic neoplasms. J Gastrointest Surg 19(6):1072-7, 2015. e-Pub 2015. PMID: 25801594.
Lindberg JM, Newhook TE, Adair SJ, Walters DM, Kim AJ, Stelow EB, Parsons JT, Bauer TW. Co-treatment with panitumumab and trastuzumab augments response to the MEK inhibitor trametinib in a patient-derived xenograft model of pancreatic cancer. Neoplasia 16(7):562-71, 2014. e-Pub 2014. PMID: 25117978.
Davies SW, Gillen JR, Guidry CA, Newhook TE, Pope NH, Hranjec T, Sawyer RG, Hallowell PT. A comparative analysis between laparoscopic and open adhesiolysis at a tertiary care center. Am Surg 80(3):261-9, 2014. e-Pub 2014. PMID: 24666867.
Newhook TE, Blais EM, Lindberg JM, Adair SJ, Xin W, Lee JK, Papin JA, Parsons JT, Bauer TW. A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest. PLoS One 9(9):e105631, 2014. e-Pub 2014. PMID: 25180633.
Johnston WF, LaPar DJ, Newhook TE, Stone ML, Upchurch GR, Ailawadi G. Association of race and socioeconomic status with the use of endovascular repair to treat thoracic aortic diseases. J Vasc Surg 58(6):1476-82, 2013. e-Pub 2013. PMID: 23911247.
Walters DM, Lindberg JM, Adair SJ, Newhook TE, Cowan CR, Stokes JB, Borgman CA, Stelow EB, Lowrey BT, Chopivsky ME, Gilmer TM, Parsons JT, Bauer TW. Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib. Neoplasia 15(2):143-55, 2013. e-Pub 2013. PMID: 23441129.
Rosenberger LH, Newhook T, Mauro DM, Hennessy SA, Sawyer RG. Jejunal tube extensions via percutaneous endoscopic gastrostomy and delayed small-bowel perforations: a case series. Gastrointest Endosc 75(3):683-7, 2012. e-Pub 2012. PMID: 22243831.
Newhook TE, Yeo CJ, Maxwell PJ. John Blair Deaver, M.D., and his marvelous retractor. Am Surg 78(2):155-6, 2012. e-Pub 2012. PMID: 22369821.
Weksler B, Tavares J, Newhook TE, Greenleaf CE, Diehl JT. Robot-assisted thymectomy is superior to transsternal thymectomy. Surg Endosc 26(1):261-6, 2012. e-Pub 2012. PMID: 21898017.
Rosenberger LH, Newhook T, Schirmer B, Sawyer RG. Late accidental dislodgement of a percutaneous endoscopic gastrostomy tube: an underestimated burden on patients and the health care system. Surg Endosc 25(10):3307-11, 2011. e-Pub 2011. PMID: 21533968.
Harris LJ, Abdollahi H, Newhook T, Sauter PK, Crawford AG, Chojnacki KA, Rosato EL, Kennedy EP, Yeo CJ, Berger AC. Optimal technical management of stump closure following distal pancreatectomy: a retrospective review of 215 cases. J Gastrointest Surg 14(6):998-1005, 2010. e-Pub 2010. PMID: 20306151.
Grant C, Oh U, Fugo K, Takenouchi N, Griffith C, Yao K, Newhook TE, Ratner L, Jacobson S. Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways. PLoS Pathog 2(4):e33, 2006. e-Pub 2006. PMID: 16652169.

Invited Articles

Vega EA, Newhook TE, Vauthey JN. ASO Author Reflections: Gallbladder Cancer Research, "One for All and All for One" Strategy to Improve Research. Ann Surg Oncol 28(5):2683-2684. e-Pub 2021. PMID: 33718976.
Newhook TE, Tzeng CD. ASO Author Reflections: Tumor Biology and Safe Surgery Remain Major Determinants of Survival After Resection of Pancreatic Adenocarcinoma. Ann Surg Oncol 28(3):1570-1571, 2021. e-Pub 2021. PMID: 32880772.
Newhook TE, Tzeng CD. ASO Author Reflections: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients. Ann Surg Oncol 26(Suppl 3):749-750, 2019. e-Pub 2019. PMID: 31559543.
Newhook TE, Badgwell BD. ASO Author Reflections: Laparoscopic Hyperthermic Intraperitoneal Chemotherapy for Patients with Metastatic Gastric Cancer. Ann Surg Oncol 26(Suppl 3):606-607, 2019. e-Pub 2019. PMID: 31069555.

Review Articles

Newhook TE, Tsai S, Meric-Bernstam F. Precision Oncology in Hepatopancreatobiliary Cancer Surgery. Surg Oncol Clin N Am 33(2):343-367, 2024. e-Pub 2024. PMID: 38401914.
Azimuddin A, Tzeng CD, Prakash LR, Bruno ML, Arvide EM, Dewhurst WL, Newhook TE, Kim MP, Ikoma N, Snyder RA, Lee JE, Perrier ND, Katz MH, Maxwell JE. Postoperative Global Period Cost Reduction Using 3 Successive Risk-Stratified Pancreatectomy Clinical Pathways. J Am Coll Surg 238(4):451-459, 2024. e-Pub 2024. PMID: 38180055.
Mason MC, Krasnodebski M, Hester CA, Kothari AN, Barker C, Nishioka Y, Chiang YJ, Newhook TE, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection. Ann Surg Oncol 29(8):5156-5164, 2022. e-Pub 2022. PMID: 35397746.
Hu Y, Edwards BL, Brooks KD, Newhook TE, Slingluff CL. Recent trends in National Institutes of Health funding for surgery: 2003 to 2013. Am J Surg 209(6):1083-9, 2015. e-Pub 2015. PMID: 25929766.

Editorials

Diggs LP, Newhook TE. Better Outcomes by Measuring Function? Predicting Functional Future Liver Remnant Using Tc-GSA SPECT/CT in Perihilar Cholangiocarcinoma. Ann Surg Oncol 32(9):6201-6202, 2025. PMID: 40389666.
Wang Y, Newhook TE. Recurrent Colorectal Liver Metastases: Opportunities for Biology-Informed Surgery Beyond Initial Hepatectomy. Ann Surg Oncol 32(3):1408-1409, 2025. PMID: 39692985.
Ayabe RI, Beaty K, Newhook TE, Cao HST, Tzeng CD, Helmink BA, Uppal A, Vauthey JN, Fournier KF, White MG. Incomplete Cytoreduction and Need for Major Hepatectomy Predict Shorter Survival in Patients Undergoing Combined Cytoreductive Surgery and Hepatectomy for Metastatic Colorectal Cancer. Ann Surg Oncol 31(10):6366-6368, 2024. PMID: 38971956.
Haddad, A, Vauthey, JN, Newhook, TE. A caution against KRAS-guided margin width during hepatectomy for colorectal liver metastases. Surgery (United States) 176(1):134-136, 2024. PMID: 38632003.
Vreeland TJ, Bohan PMK, Newhook TE, Allen CJ, Prakash LR, Maxwell JE, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CD. Contemporary Assessment of Need for Palliative Bypass After Aborted Pancreatoduodenectomy Following Neoadjuvant Therapy. J Gastrointest Surg 26(2):352-359, 2022. PMID: 35064457.
Newhook TE, Chun YS, Vauthey JN. An Odyssey into the Land of Deleterious Rare Mutations in Colorectal Liver Metastases. Ann Surg Oncol 27(9):3115-3117, 2020. PMID: 32651694.
Newhook TE, Aloia TA. Invited Editorial: The Southampton Consensus Guidelines for Laparoscopic Liver Surgery: From Innovation to Implementation. Ann Surg 268(1):19-21, 2018. PMID: 29727325.

Abstracts

Newhook TE, Haddad A, Wang Y, Arvide EM, Mrema DE, Munoz-Alfaro KD, Kell RJ, Morris VK, Dasari AN, Konishi T, Chin YS, Tran Cao HS, C-WD T, Kopetz SW, Vauthey JN, Newhook TE. Postoperative ctDNA Is Associated with Outcomes after Curative-intent Hepatectomy: Results from the Intercept Program. IHPBA: International Hepato-Pancreato Biliary Association 27(HPB):S225, 2025. e-Pub 2025.
Haddad, A, Khavandi, MM, Lendoire, M, Belkacem, A, Chiang, YJ, Gupta, S, Tam, AL, Odisio, BC, Mahvash, A, Abdelsalam, ME, Lin, EY, Kuban, JD, Newhook, TE, Tran Cao, HS, Tzeng, CD, Huang, SY, Vauthey, JN, Habibollahi, P. ASO Visual Abstract. Annals of surgical oncology 32(4):2495-2496, 2025. e-Pub 2025. PMID: 39838241.
Boyev, A, Tzeng, CD, Maki, H, Arvide, EM, Mrema, DE, Jain, AJ, Haddad, A, Lendoire, M, Malik, N, Odisio, BC, Chun, YS, Tran Cao, HS, Vauthey, JN, Newhook, TE. ASO Visual Abstract. Annals of surgical oncology 31(4):2606, 2024. e-Pub 2024. PMID: 38252264.
Swords DS, Newhook TE, Tzeng CD, Massarweh NN, Chun YS, Lee S, Kaseb AO, Ghobrial M, Vauthey JN, Tran Cao HS. ASO Visual Abstract: Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma. Ann Surg Oncol 30(13):8019-8020, 2023. e-Pub 2023. PMID: 37782416.
Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JN. ASO Visual Abstract: Hepatectomy Before Primary Tumor Resection as the Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol 30(9):5403-5404, 2023. e-Pub 2023. PMID: 37358681.
Vega EA, Mellado S, Newhook TE, Vauthey JN. ASO Visual Abstract: Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multi-center Study. Ann Surg Oncol 30(8):4914-4915, 2023. e-Pub 2023. PMID: 37179275.
Vega EA, Mellado S, Newhook TE, Vauthey JN. ASO Visual Abstract: Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multi-center Study. ANN SURG ONC. e-Pub 2023. PMID: 37179275.
Newhook TE, Tran Cao HS, Chun YS, Tzeng CWD, Vauthey JN. KRAS-G12V and TP53 But Not KRAS-G12V Mutation Alone Is Associated with Worse Survival in Patients with Resected Colorectal Liver Metastasis. Abstract presented at the 2023 Society of Surgical Oncology Annual Meeting, 2023. e-Pub 2023.
Lilley E, Maxwwell J, Newhook T, Ikoma N, Tzeng C, Badgwell B, Lee J, Vauthey JN, Katz M, Tran Cao H. Hospital volume and regional variation are associated with palliative surgery for patients with metastatic gastrointestinal malignancies. Abstract presented at the Society of Asian Academic Surgeons (SAAS) Annual Meeting 2022, 2022. e-Pub 2022.
Ayabe R, Arvide M, Dewhurst W, Prakash L, Jin A, Tran Cao H, Newhook T, Chun YS, Vauthey JN, Tzeng CW. Anticipated weekday vs. weekend discharges and association with post-hepatectomy length of stay. Abstract presented at the Society of Asian Academic Surgeons (SAAS) Annual Meeting 2022, 2022. e-Pub 2022.
Ikoma N, Tran Cao H, Newhook T, Maxwell J, Kim M, Tzeng CW, Chun YS, Lee J, Vauthey JN, Katz M. Strategic approach to building a robotic foregut surgical oncology program at a tertiary cancer hospital. Abstract presented at the Society of Asian Academic Surgeons (SAAS) Annual Meeting 2022, 2022. e-Pub 2022.
Newhook TE, overman MJ, Chun YS, Dasari A, Tzeng CW, Tran Cao HS, Raymond V, parseghian C, Johnson B, Nichioka Y, Kawaguchi Y, Uppal A, Vreeland TJ, Jaimovich A, Arvide AM, Cristo JV, Wei SH, Raghav KP, Morris VK, Lee JE, Kopetz S, Vauthey JN. A Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver Metastases. Poster presented at the 2022 TRANSCEND Symposium, 2022. e-Pub 2022.
Nishioka Y, Chun YS, Overman MJ, Tran Cao HST, Tzeng CD, Mason MC, Kopetz SW, Bauer TW, Vauthey JN, Newhook TE, Program MD. Co-Mutation Of Ras+Tp53 Is Associated With Postoperative Ctdna Detection And Early Recurrence After Hepatectomy For Colorectal Liver Metastases. SSA 2021, 2022. e-Pub 2022. PMID: 35290266.
prakash LR, Arvide E, Newhook TE, Bruno ML, Dewhurst WL, je M, Lee J, Kim M, Katz M, C-WD T, Ikoma N. Comparative analysis of opioid use between robotic and open pancreaticoduodenectomy. E-poster presented at SSO 2022, 2022. e-Pub 2022.
Newhook TE, Overman MJ, Chun YS, Dasari A, Tzeng CW, Tran Cao HS, Raymond V, parseghian C, Johnson B, Nichioka Y, Kawaguchi Y, Uppal A, Vreeland TJ, Jaimovich A, Arvide AM, Cristo JV, Wei SH, Raghav KP, Morris VK, Lee JE, Kopetz S, Vauthey JN. A Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver Metastases. Poster presented at the 2022 TRANSCEND Symposium, 2022. e-Pub 2022.
Witt R, Newhook T. Impact of First-Day Intravenous Patient Controlled Analgesia Use on Total Inpatient Opioid Use after Pancreatectomy. SAAS 6th Annual Meeting, 2021. e-Pub 2021.
Paez-Arango N, Estrella JS, Newhook T, Tzeng CWD, Chun YS, Lee S, Javle M, Vauthey JN, Tran Cao HS. Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma - does pathologic response mean better outcome?. AHPBA 2021 Annual Meeting, 2021. e-Pub 2021.
Swords DS, Prakash L, Newhook TE, Tran Cao HS, Ikoma N, Maxwell J, Kim MP, Lee JE, Katz MHG, Tzeng CWD. Neighborhood-level socioeconomic status and outcomes in patients with localized pancreatic adenocarcinoma treated with first-line FOLFIRINOX. Mini Oral presentation at the AHPBA 2021 Annual Meeting, 2021. e-Pub 2021.
Martin AN, Tzeng CWD, Arvide EM, Skibber JM, Chang GJ, You YQN, Bednarski BK, Dewhurst WL, Cristo JV, Chun YS, Tran Cao HS, Vauthey JN, Newhook TE. Cumulative operative time and postoperative complication risk in synchronous resections of colorectal liver metastases and primary tumors. AHPBA 2021 Annual Meeting, 2021. e-Pub 2021.
Swords, DS, Newhook, TE, Tzeng, CWD, Chun, Y, Aloia, T, Kaseb, A, Vauthey, JN, Cao T, H. Disparities in use of surgical treatments mediate half of socioeconomic survival disparities in stage I-II hepatocellular carcinoma. 2021 DDW SSAT Annual Meeting, 2021. e-Pub 2021.
Kim BJ, Arvide EM, Kawaguchi Y, Dewhurst WL, Phan TL, Tran Cao H, Aloia T, Chun YS, Katz M, Vauthey JN, Tzeng CW, Newhook TE. Utilization of the Kawaguchi-Gayet Complexity classification to create, implement, and validate risk-stratified post-hepatectomy pathways based on anticipated length of stay, 2021. e-Pub 2021.
Arango NP, Nishioka Y, Kawaguchi Y, Boettcher FO, Newhook TE, CHun Y, Aloia T, Tzeng CD, Tran Cao H, Lee J, Vreeland TJ, Vauthey J. Neither surgical margin status nor somatic mutation predicts local recurrence after R0-intent resection for colorectal liver metastases, 2021. e-Pub 2021.
Gaskill CE, Kim BJ, Newhook TE, Avide EM, Dewhurst WL, Phan TL, Cristo J, Tran Cao HS, Aloia TA, Chung YS, Vauthey JN, Tzeng CWD. Every drop matters: intraoperative fluids during hepatectomy and postoperative ileus, 2021. e-Pub 2021.
Kim BJ, Newhook TE, Tzeng CWD, Ikoma N, Chiang YJ, Chun YS, Aloia TA, Vauthey JN, Tran Cao HS. Oncologic quality metrics for biliary tract cancer surgery - differential performance by approach. Cholangiocarcinoma Foundation Annual Conference, 2021. e-Pub 2021.
Newton AD, Newhook TE, Ikoma N, White MG, Tzeng CD, Chun YS, Aloia TA, Vauthey JN, Tran Cao HS. Robotic completion radical cholecystectomy with fluorescence guidance. SSO 2021 International Conference on Surgical Cancer Care, 2021. e-Pub 2021.
Martin AN, Arvide EM, Newhook TE, DiBrito SR, Kim B, Dewhurst W, Lee T, Kawaguchi Y, Tran Cao HS, Aloia T, Chun Y, Katz M, Vauthey JN, Tzeng CW. Post-hepatectomy pathways: Using inpatient risk-stratification to inform outpatient follow-up. 2021 DDW SSAT Annual Meeting, 2021. e-Pub 2021.
Newton AD, Newhook TE, Bruno ML, Prakash LR, Chiang YJ, Arango NP, Dewhurst WL, ArvideEM, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CW. Iterative changes in risk-stratified pancreatectomy clinical pathways and factos associated with accelerated discharge after pancreaticoduodenectomy. 2021 DDW SSAT Annual Meeting, 2021. e-Pub 2021.
Kim BJ, Newhook TE, Tzeng CWD, Ikoma N, Chiang YJ, Chun YS, Aloia TA, Vauthey JN, Tran Cao HS. Minimally invasive approaches to biliary tract cancers and nodal sampling: not all approaches are similar. IHPBA 14th Annual World Congress, 2021. e-Pub 2021.
Mason MC, Krasnodebski M, Barker C, Nichioka Y, Kothari AN, Chiang YJ, Newhook TE, Tzeng CWD, Chun YS, Aloia T, Vauthey JN, Tran Cao H. Outcomes of mixed pathologic response in patients with multiple colorectal liver metastases treated with neoadjuvant chemotherapy and liver resection. 2021 DDW SSAT Annual Meeting, 2021. e-Pub 2021.
Newhook T, Kim MP, Chiang YJ, Ikoma N, Tzeng CW, Vauthey JN, Lee JE, Katz MHG, Tran Cao HS. Oncologic outcomes of cyst-associated vs. classical pancreatic ductal adenocarcinoma. Digestive Disease Week (SSAT) Virtual - 2020, 2020. e-Pub 2020.
Kim BJ, Newhook TE, Tzeng CWD, Ikoma N, Chiang YJ, Chun YS, Aloia TA, Vauthey JN, Tran Cao HS. Minimally invasive approaches to biliary tract cancers and nodal sampling: not all approaches are similar. AHPBA 2020 Annual Meeting, 2020. e-Pub 2020.
Kawaguchi Y, Newhook TE, Tran Cao HS, Tzeng CD, Chun YS, Aloia TA, Kopetz S, Vauthey JN. Alteration of FBXW7 is associated with worse survival in patients undergoing resection of colorectal liver metastases. Society for Surgery of the Alimentary Tract Annual Meeting (virtual), Plenary Session, 2020. e-Pub 2020.
Day RW, Newhook TE, Dewhurst WL, Arvide EM, Bruno M, Kim MP, Tran Cao HS, Ikoma N, Chun YS, Aloia TA, Katz MHG, Lee JE, Vauthey JN, Tzeng CD. Patient-specific opioid volume calculations reduce discharge prescriptions after hepato-pancreato-biliary surgery, 2020. e-Pub 2020.
Allen CJ, Newhook TE, Vreeland TJ, Das P, Minsky B, Blum M, Roy-Chodhuri S, Ajani J, Ikoma N, Mansfield PF, Badgwell BB. Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma. 72nd Society of Surgical Oncology Annual Cancer Symposium, 2019. e-Pub 2019.
Allen CJ, Newhook TE, Vreeland TJ, Das P, Minsky B, Blum M, Ajani J, Ikoma N, Mansfield PF, Badgwell BB. Prognostic value of lymph node yield following neoadjuvant chemoradiation for gastric adenocarcinoma. 72nd Society of Surgical Oncology Annual Cancer Symposium, 2019. e-Pub 2019.
Vreeland TJ, Vicente DA, Day RW, Allen CJ, Newhook TE, Grubbs E, Bednarski B. “Flipping the surgical classroom”: using modern technology to improve surgical education. Academic Surgical Congress, 2019. e-Pub 2019.
Vicente D, Lee AJ, Hall CS, Lucci A, Vreeland T, Newhook T, Lee JE, Kim MP, Katz MHG, Hurd M, Alvarez H, Maitra A, Rhim AD, Tzeng CW. Circulating tumor cells and transforming growth factor beta in pancreatic adenocarcinoma. Academic Surgical Congress, 2019. e-Pub 2019.
Allen CJ, Newhook TE, Vreeland TJ, Das P, Minsky B, Blum M, Roy-Chodhuri S, Ajani J, Ikoma N, Mansfield PF, Badgwell BB. Yield of peritoneal washings and cytology in staging patients with gastric and gastroesophageal cancer. 72nd Society of Surgical Oncology Annual Cancer Symposium, 2019. e-Pub 2019.
Vreeland TJ, Newhook TE, Prakash LR, Dewhurst WL, Bruno ML, Aloia TA, Vauthey JN, Lee JE, Kim MP, Katz MHG, Tzeng CW. Natural history of disese progression and interventions after aborted pancreaticoduodenectomy for pancreatic adenocarcinoma. Digestive Disease Week, 2019. e-Pub 2019.
Lillemoe H, Vreeland TJ, Newhook TE, Arvide EM, Dewhurst W, Grubbs E, Aloia TA, Lee JE, Tzeng CD. Educating providers on perioperative opioids in surgical oncology: results of a departmental survey on perceptions of opioid needs and prescribing habits, 2019. e-Pub 2019.
Dewhurst W, Newhook TE, Chen HC, Wang X, Bruno M, Kim M, Vauthey JN, Lee J, Katz M, Tzeng CW. Impact of first-day intravenous patient controlled analgesia use on total inpatient opioid use after pancreatectomy. International Hepato-Pancreato-Biliary Association 13th World Congress, 2018. e-Pub 2018.
Newhook TE, Agnes A, Blum M, Estrella J, Chowdhuri SR, Matamoros A, Das P, Ho L, Ajani J, Badgwell B. Laparoscopic hyperthermic intraperitoneal chemotherapy is safe for patients with peritoneal metastases from gastric cancer and may lead to gastrectomy. 71st Society of Surgical Oncology Annual Cancer Symposium, 2018. e-Pub 2018.
Joechle K, Vega EA, Okuno M, Satoshi O, Newhook TE, Ramirez DL, Holmes AA, Chun YS, Tzeng CWD, Lee JE, Vauthey JC, Conrad C. Peripheral-to-central transection along the middle hepatic vein for laparoscopic right hepatectomy. Americas Hepato-Pancreato-Biliary Association Annual Meeting, 2018. e-Pub 2018.
Newhook TE, Dewhurst W, Chen HC, Wang X, Kim M, Aloia T, Vauthey JN, Lee J, Katz M, Tzeng CW. Variation in and predictors of inpatient opioid utilization after pancreatectomy. International Hepato-Pancreato-Biliary Association 13th World Congress, 2018. e-Pub 2018.
Griffin JF, Newhook TE, Vreeland TJ, Prakash L, Kim MP, Ikoma N, Vauthey JN, Katz MHG, Lee JE, Tzeng CD. Baseline CA19-9 at diagnosis stratifies prognosis in patients with resected pancreatic adenocarcinoma treated with neoadjuvant therapy or surgery-first sequencing. AHPBA Annual Meeting, 2018. e-Pub 2018.
Kim BJ, Gaskill C, Newhook TE, Arvide EM, Dewhurst WL, Tran Cao HS, Chun YS, Aloia TA, Vauthey JN, Tzeng CD. Utilization of the Kawaguchi-Gayet complexity classification to stratify hepatectomy patients for distinct enhanced recovery pathways based on anticipated length of stay, 2018. e-Pub 2018.
Newhook TE, Michaels AD, Adair SJ, Morioka S, Lindberg JM, Parsons JT, Bauer TW. Occult metastatic pancreatic cancer cells stimulate an innate immune response in the liver microenvironment. University of Virginia Department of Surgery Annual Resident Research Day, 2017. e-Pub 2017.
Newhook TE, Michaels AD, Adair SJ, Morioka S, Lindberg JM, Parsons JT, Bauer TW. Occult metastatic pancreatic cancer cells stimulate an innate immune response in the liver microenvironment. 70th Society of Surgical Oncology Annual Cancer Symposium, 2017. e-Pub 2017.
Mullen MG, Newhook TE, Lindberg JM, Adair S, Blais EM, Parsons JT, Bauer TW. Smoking Results in Distinct Alterations in Gene Expression and Upregulation of Protein Glycosylation in Pancreatic Cancers. The American College of Surgeons Virginia Chapter and Virginia Surgical Society, 2014. e-Pub 2014.
Newhook TE, LaPar DJ, Lindberg JM, Bauer TW, Adams RB, Zaydfudim VM. Morbidity and mortality of hepatectomy for benign liver tumors. Digestive Disease Week, 2014. e-Pub 2014.
Newhook TE, LaPar DJ, Lindberg JM, Bauer TW, Adams RB, Zaydfudim VM. Morbidity and mortality of pancreaticoduodenectomy for premalignant pancreatic neoplasms. The Pancreas Club Annual Meeting, 2014. e-Pub 2014.
Newhook TE, Lindberg JM, Adair SJ, Blais E, Papin JA, Gray LS, Parsons JT, Bauer TW. Combination therapy with a MEK inhibitor plus T-type calcium channel inhibitor is highly effective in patient-derived pancreatic adenocarcinomas. American Association for Cancer Research Annual Meeting, 2014. e-Pub 2014.
Newhook TE, Lindberg JM, Adair SJ, Parsons JT, Bauer TW. The MEK inhibitor trametinib delays tumor outgrowth and prolongs survival in a patient-derived model of occult metastatic hepatic pancreatic cancer. The American Association for Cancer Research Annual Meeting, 2014. e-Pub 2014.
Newhook TE, Lindberg JM, Adair SJ, Kim A, Parsons JT, Bauer TW. Combined proteasome and MEK inhibition results in enhanced growth inhibition of patient-derived pancreatic ductal adenocarcinoma, 2014. e-Pub 2014.
Newhook TE, Lindberg JM, Adams RB, Bauer TW. Preoperative bowel preparation for pancreaticoduodenectomy – is it necessary?. 66th Annual Society of Surgical Oncology Annual Cancer Symposium, 2013. e-Pub 2013.
Newhook TE, Lindberg JM, Strong A, Adams RB, Bauer TW. Preoperative bowel preparation for pancreaticoduodenectomy – is it necessary?. 2013 Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology, 2013. e-Pub 2013.
Newhook TE, Lindberg JM, Adair SJ, Parsons JT, Bauer TW. The MEK inhibitor trametinib delays tumor outgrowth and prolongs survival in a patient-derived model of occult metastatic hepatic pancreatic cancer. The American Association for Cancer Research Special Meeting on the Translational Impact of Model Organisms in Cancer, 2013. e-Pub 2013.

Book Chapters

Haddad, A, Newhook, TE. Hepatic procedures. Third Edition. Springer, 461-485, 2024.
Newhook TE, Aloia TA. Enhanced Recovery after Surgery (ERAS) Protocols. In: Principles of Perioperative Safety and Efficiency. Springer, 277-293, 2024.
Newhook, TE, Aloia, TA. Enhanced Recovery After Surgery Protocols, 277-293, 2024.
Newhook TE, Aloia TA. Enhanced Recovery Programs in Hepatobiliary Surgery. In: Blumgart’s Surgery of the Liver, Biliary Tract, and Pancreas. 7th. Elsevier, 390-394, 2023.
Newhook, TE, Kawaguchi, Y. Circulating Tumour DNA and Risk-Stratified Surveillance Strategies for Patients with Colorectal Liver Metastases. In: Colorectal Liver Metastasis, 557-562, 2022.
Newhook, TE, Tzeng, CD. Exposure for Hepatectomy. In: Colorectal Liver Metastasis, 23-28, 2022.
Kawaguchi, Y, Newhook, TE. Conditional Recurrence-Free Survival. In: Colorectal Liver Metastasis, 261-263, 2022.
Newhook TE, Adams JD, Upchurch GR. Splenic Artery Aneurysm. In: Clinical Scenarios in Vascular Surgery. Wolters Kluewer, 388-391, 2015.
Newhook TE, Badgwell BD. Minimally Invasive Hyperthermic Intraperitoneal Perfusion for Gastric Cancer. In: Minimally Invasive Surgical Techniques for Cancers of the Gastrointestinal Tract : A Step-by-Step Approach. 2nd. Springer, 93.

Letters to the Editor

Kawaguchi Y, Kopetz S, Newhook TE, De Bellis M, Chun YS, Tzeng CD, Aloia TA, Vauthey JN. Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases. Clin Cancer Res 25: 5843-5851, 2019.
Newhook TE, Badgwell BD. Reply to the Letter to the Editor Regarding "Laparoscopic Hyperthermic Intraperitoneal Chemotherapy is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy". Ann Surg Oncol 26: 3011-3012, 2019.

Less

CV information above last modified March 31, 2026

Timothy E Newhook, MD, FSSO, FACS

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Licenses & Certifications

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Other Articles

Editorials

Abstracts

Book Chapters

Letters to the Editor

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

Timothy E Newhook, MD, FSSO, FACS

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Licenses & Certifications

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Other Articles

Editorials

Abstracts

Book Chapters

Letters to the Editor

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Shop UT MD Anderson